David E. Lazar's Net Worth
$7.86 Million
Who is David E. Lazar?
David E. Lazar has an estimated net worth of $7.86 Million. This is based on reported shares across multiple companies, which include MINIM, INC., and TITAN PHARMACEUTICALS INC.
SEC CIK
David E. Lazar's CIK is 0001932843
Past Insider Trading and Trends
2022 was David E. Lazar's most active year for acquiring shares with 3 total transactions. David E. Lazar's most active month to acquire stocks was the month of December. 2023 was David E. Lazar's most active year for disposing of shares, totalling 4 transactions. David E. Lazar's most active month to dispose stocks was the month of May. 2024 saw David E. Lazar paying a total of $2,800,000.00 for 4,800,000 shares, this is the most they've acquired in one year. In 2023 David E. Lazar cashed out on 7,495,936 shares for a total of $9,220,001.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MINIM, INC. (MINM) Snapshot price: $4.93
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TITAN PHARMACEUTICALS INC (TTNP) Snapshot price: $6.2
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jul 26
| |||
Form 4/A
| -100.00% | -3.75M |
$1.23 | -$4,610,000.64 |
0
|
Jun 21
| |||
Form 4
| -100.00% | -3.75M |
$1.23 | -$4,610,000.64 |
0
|
Jun 21
| |||
Form 4
| +1.73% | 57.5K |
$0.98 | $56,287.25 | 3.39M |
Jan 24 - Jan 25
| |||
Form 4
| +152.03% | 2.23M |
$0.88 | $1,922,882.26 | 3.69M |
Jul 6 - Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPGEN INC (OPGN) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tracon Pharmaceuticals, Inc. (TCON) No price found
Chief Business Dev Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||